RSS

Chemotherapy

Developer of scalp cooling technology Paxman, alongside the University of Huddersfield have been nominated for a higher education Oscar at the Times Higher Education (THE) Awards. more

News

An organisation led by six globally-recognised experts in cancer care has launched an initiative to track evidence-based patient information and clinical guidance. more

News

The US Food and Drug Administration (FDA) has cleared Paxman Coolers to market its Paxman Scalp Cooling System. more

Devices

Scalp cooling pioneer Paxman will run a masterclass discussing the importance of scalp cooling to patients and examine the science behind it. more

News

Medical device company, Paxman, has announced that it has filed an application with the FDA to market an advanced scalp cooling technology for the prevention of hair loss in women undergoing certain forms of chemotherapy for breast cancer. more

News